Myocardial infarction: ACE inhibitors for all? for ever?

ACE inhibitors after myocardial infarction: patient selection or treatment for all?

It is now clear that angiotensin-converting enzyme (ACE) inhibitors have an important role in the management of patients after myocardial infarction. Several clinical trials have shown statistically significant reductions in mortality (SAVE, AIRE, GISSI-3, ISIS4).1-4 Some may argue that the weight of evidence favours wide, if not universal, use of ACE inhibitors among post-infarct patients. Doe...

ACE inhibitors in acute myocardial infarction: patient selection and timing.

Angiotensin-converting enzyme inhibitors have earned their place along with aspirin, b-blockers, and thrombolytic agents as medical therapies proven to reduce mortality rates in acute myocardial infarction. The results of well-conducted, randomized, controlled clinical trials have been so consistent and so conclusive that the emphasis now shifts from research to implementation. Because the tria...

What to expect from ACE inhibitors after myocardial infarction.

Indications for ACE Inhibitors in the Early Treatment of Acute Myocardial Infarction

Indications for ACE Inhibitors in the Early Treatment of Acute Myocardial Infarction : Print ISSN: 0009-7322. Online ISSN: 1524-4539 Copyright © 1998 American Heart Association, Inc. All rights reserved. is published by the American Heart Association, 7272 Greenville Avenue, Dallas, TX 75231 Circulation doi: 10.1161/01.CIR.97.22.2202 1998;97:2202-2212 Circulation. http://circ.ahajournals.org/co...

ACE inhibitors vs. angiotensin II receptor blockers in acute myocardial infarction and heart failure.